Malarone

GPTKB entity

Statements (60)
Predicate Object
gptkbp:instance_of gptkb:drug
gptkbp:bfsLayer 5
gptkbp:bfsParent gptkb:Ciba-Geigy
gptkbp:activities inhibits mitochondrial electron transport
gptkbp:appointed_by oral tablet
gptkbp:approves gptkb:2000
gptkb:FDA
gptkbp:availability widely available in pharmacies
gptkbp:clinical_trial Phase III
malaria treatment
malaria prophylaxis
gptkbp:contains atovaquone
proguanil
gptkbp:contraindication hypersensitivity to components
severe renal impairment
gptkbp:developed_by gptkb:Glaxo_Smith_Kline
gptkbp:dosage_form gptkb:tablet
1 tablet daily for prevention
4 tablets for treatment on first day
gptkbp:duration 3 days for acute malaria
daily for prevention
gptkbp:education take with food
report any severe side effects
complete full course of treatment
gptkbp:formulation fixed-dose combination
https://www.w3.org/2000/01/rdf-schema#label Malarone
gptkbp:ingredients atovaquone
proguanil hydrochloride
gptkbp:interacts_with gptkb:warfarin
certain antiretroviral drugs
gptkbp:invention gptkb:2015
gptkbp:is_available_on generic version
gptkbp:is_effective_against P. malariae
P. ovale
high against P. falciparum
moderate against P. vivax
gptkbp:is_monitored_by renal function
liver function
gptkbp:is_used_for treatment of malaria
prevention of malaria
gptkbp:manager oral
gptkbp:marketed_as Malarone brand name
gptkbp:packaging blister pack
gptkbp:price varies by region
gptkbp:requires prescription only
gptkbp:research_focus combination therapies
resistance patterns
gptkbp:shelf_life 3 years
gptkbp:side_effect headache
nausea
abdominal pain
diarrhea
liver enzyme elevation
skin rash
gptkbp:storage room temperature
gptkbp:suitable_for severe liver disease
pregnant women without consultation
children under 5 kg
travelers to malaria-endemic areas
gptkbp:takes_place_in food to enhance absorption